Impaired tumor growth and angiogenesis in mice heterozygous for Vegfr2 (Flk1)
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impaired tumor growth and angiogenesis in mice heterozygous for Vegfr2 (Flk1)
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-27
DOI
10.1038/s41598-018-33037-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma
- (2017) Yujie Huang et al. JOURNAL OF CLINICAL INVESTIGATION
- A refined method to study gene dosage changes in vitro using CRISPR/Cas9
- (2017) Teresa P Raposo et al. JOURNAL OF CLINICAL PATHOLOGY
- FGF-dependent metabolic control of vascular development
- (2017) Pengchun Yu et al. NATURE
- Reduction in the copy number and expression level of the recurrent human papillomavirus integration gene fragile histidine triad (FHIT) predicts the transition of cervical lesions
- (2017) Liming Wang et al. PLoS One
- Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury
- (2016) Stacey L. House et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions
- (2016) Zhexuan Lin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors
- (2016) Yongkun Sun et al. Journal of Hematology & Oncology
- Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
- (2015) Karolina Tecza et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Ramucirumab, another anti-angiogenic agent for metastatic colorectal cancer in second-line setting—its impact on clinical practice
- (2015) Gaurav Goel et al. Journal of Hematology & Oncology
- Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor
- (2015) Y. Zhao et al. ONCOLOGIST
- Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis
- (2014) Sunday S. Oladipupo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-VEGF Therapies in the Clinic
- (2013) K. L. Meadows et al. Cold Spring Harbor Perspectives in Medicine
- Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?
- (2013) Tom Donnem et al. Cancer Medicine
- Resistance and Escape From Antiangiogenesis Therapy: Clinical Implications and Future Strategies
- (2012) Justin N. Bottsford-Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Overcoming Resistance to Antiangiogenic Therapies
- (2012) S. Tejpar et al. ONCOLOGIST
- The Double Edged Sword of Bleeding and Clotting from VEGF Inhibition in Renal Cancer Patients
- (2012) Guru Sonpavde et al. Current Oncology Reports
- Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence
- (2011) S. S. Oladipupo et al. BLOOD
- Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis
- (2011) C. Lieu et al. CLINICAL CANCER RESEARCH
- Signaling Pathways Governing Tumor Angiogenesis
- (2011) Toshiharu Sakurai et al. ONCOLOGY
- Gene dosage effects in chronic lymphocytic leukemia
- (2010) Ludger Sellmann et al. CANCER GENETICS AND CYTOGENETICS
- Glomerular Structure and Function Require Paracrine, Not Autocrine, VEGF-VEGFR-2 Signaling
- (2010) K. Sison et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications
- (2009) Erika L Abel et al. Nature Protocols
- Both primitive and definitive blood cells are derived from Flk-1+ mesoderm
- (2008) J. J. Lugus et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More